
New Drug Doubles Survival Time For Pancreatic Cancer Patients
Could a single daily pill finally change the outlook for one of the deadliest cancers in the world? Scientists believe a new drug may have done just that. Researchers say a treatment called daraxonrasib has nearly doubled survival times for patients with advanced pancreatic cancer. Offering fresh hope against a disease that has long been










